AT525409A3 - Medizinisches Pflaster mit langsamer Freisetzung - Google Patents
Medizinisches Pflaster mit langsamer Freisetzung Download PDFInfo
- Publication number
- AT525409A3 AT525409A3 ATA9160/2021A AT91602021A AT525409A3 AT 525409 A3 AT525409 A3 AT 525409A3 AT 91602021 A AT91602021 A AT 91602021A AT 525409 A3 AT525409 A3 AT 525409A3
- Authority
- AT
- Austria
- Prior art keywords
- medicated patch
- slow release
- sodium salt
- release medicated
- diclofenac
- Prior art date
Links
- 229940066974 medicated patch Drugs 0.000 title abstract 2
- 239000011505 plaster Substances 0.000 abstract 2
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical class [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002998 adhesive polymer Substances 0.000 abstract 1
- 229960001259 diclofenac Drugs 0.000 abstract 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Finger-Pressure Massage (AREA)
Abstract
Es wird ein medizinisches Pflaster mit langsamer Freisetzung auf der Basis von Diclofenac beschrieben, insbesondere ein medizinisches Pflaster auf der Basis von Diclofenac-Natriumsalz, dessen Formulierung die kontinuierliche Freisetzung des Wirkstoffs in lokal therapeutisch wirksamen Konzentrationen über 24 Stunden ermöglicht, sowie die adhäsive Polymermatrix (PSA) zur Verwendung in einem medizinischen Pflaster auf der Basis von Diclofenac-Natriumsalz.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000011686A IT202000011686A1 (it) | 2020-05-20 | 2020-05-20 | Cerotto medicato a lento rilascio |
PCT/IB2021/054261 WO2021234562A1 (en) | 2020-05-20 | 2021-05-18 | Slow-release medical plaster |
Publications (2)
Publication Number | Publication Date |
---|---|
AT525409A2 AT525409A2 (de) | 2023-03-15 |
AT525409A3 true AT525409A3 (de) | 2023-04-15 |
Family
ID=71994907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ATA9160/2021A AT525409A3 (de) | 2020-05-20 | 2021-05-18 | Medizinisches Pflaster mit langsamer Freisetzung |
Country Status (35)
Country | Link |
---|---|
US (1) | US20230190668A1 (de) |
EP (1) | EP4153151B1 (de) |
KR (1) | KR20230013033A (de) |
CN (1) | CN115666537A (de) |
AR (1) | AR122136A1 (de) |
AT (1) | AT525409A3 (de) |
BE (1) | BE1028251B1 (de) |
CA (1) | CA3178964A1 (de) |
CH (1) | CH718822B1 (de) |
CZ (1) | CZ2022461A3 (de) |
DE (1) | DE112021002871T5 (de) |
DK (2) | DK4153151T3 (de) |
EE (1) | EE05862B1 (de) |
ES (2) | ES2936185R1 (de) |
FI (1) | FI4153151T3 (de) |
FR (1) | FR3110397A1 (de) |
GB (1) | GB2610106A (de) |
GR (1) | GR1010304B (de) |
HR (1) | HRP20240192T1 (de) |
HU (1) | HUP2200459A2 (de) |
IE (1) | IE20210109A1 (de) |
IT (1) | IT202000011686A1 (de) |
LT (1) | LT4153151T (de) |
LU (1) | LU501245B1 (de) |
MA (1) | MA59594B1 (de) |
MD (1) | MD4153151T2 (de) |
NL (1) | NL2028233B1 (de) |
PL (2) | PL4153151T3 (de) |
PT (1) | PT4153151T (de) |
RO (1) | RO137440A2 (de) |
RS (1) | RS65194B1 (de) |
SI (1) | SI4153151T1 (de) |
SK (1) | SK500562022A3 (de) |
TR (1) | TR2021008324A2 (de) |
WO (1) | WO2021234562A1 (de) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060078604A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
WO2006097149A1 (en) * | 2005-03-17 | 2006-09-21 | Pharmafilm S.R.L. | An aqueous polymeric system for pressure sensitive adhesive matrix preparation |
US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
WO2012089256A1 (en) * | 2010-12-29 | 2012-07-05 | Pharmafilm S.R.L. | Medicated patch for improved transdermal permeation of diclofenac diethylammonium |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09208463A (ja) * | 1996-02-07 | 1997-08-12 | Tsumura & Co | 経皮吸収性に優れた消炎鎮痛組成物 |
JP4181232B2 (ja) * | 1997-07-18 | 2008-11-12 | 帝國製薬株式会社 | ジクロフェナクナトリウム含有油性外用貼付製剤 |
JP4865958B2 (ja) * | 2001-05-23 | 2012-02-01 | 株式会社トクホン | 鎮痛抗炎症局所作用型の貼付剤 |
CN1215838C (zh) * | 2003-06-25 | 2005-08-24 | 蚌埠丰原医药科技发展有限公司 | 双氯芬酸钠贴剂及其制备方法 |
WO2012160125A1 (en) * | 2011-05-26 | 2012-11-29 | Novartis Ag | Compositions for percutaneous administration of physiologically active agents |
PT2865378T (pt) * | 2012-06-20 | 2018-01-15 | Hisamitsu Pharmaceutical Co | Adesivo para a pele |
EP3206673A1 (de) | 2014-10-17 | 2017-08-23 | Fidia Farmaceutici S.p.A. | System zur dermalen therapie mit hoher haftbarkeit |
-
2020
- 2020-05-20 IT IT102020000011686A patent/IT202000011686A1/it unknown
-
2021
- 2021-05-11 GR GR20210100319A patent/GR1010304B/el active IP Right Grant
- 2021-05-18 KR KR1020227040002A patent/KR20230013033A/ko unknown
- 2021-05-18 MA MA59594A patent/MA59594B1/fr unknown
- 2021-05-18 CZ CZ2022-461A patent/CZ2022461A3/cs unknown
- 2021-05-18 EP EP21726205.4A patent/EP4153151B1/de active Active
- 2021-05-18 RO ROA202200733A patent/RO137440A2/ro unknown
- 2021-05-18 CH CH001380/2022A patent/CH718822B1/it not_active IP Right Cessation
- 2021-05-18 CN CN202180036277.8A patent/CN115666537A/zh active Pending
- 2021-05-18 ES ES202290075A patent/ES2936185R1/es active Pending
- 2021-05-18 FI FIEP21726205.4T patent/FI4153151T3/fi active
- 2021-05-18 SI SI202130104T patent/SI4153151T1/sl unknown
- 2021-05-18 EE EEP202200014A patent/EE05862B1/et unknown
- 2021-05-18 DK DK21726205.4T patent/DK4153151T3/da active
- 2021-05-18 PL PL21726205.4T patent/PL4153151T3/pl unknown
- 2021-05-18 NL NL2028233A patent/NL2028233B1/en active
- 2021-05-18 PL PL442805A patent/PL442805A1/pl unknown
- 2021-05-18 WO PCT/IB2021/054261 patent/WO2021234562A1/en active Application Filing
- 2021-05-18 SK SK50056-2022A patent/SK500562022A3/sk unknown
- 2021-05-18 GB GB2217015.3A patent/GB2610106A/en active Pending
- 2021-05-18 AT ATA9160/2021A patent/AT525409A3/de unknown
- 2021-05-18 HR HRP20240192TT patent/HRP20240192T1/hr unknown
- 2021-05-18 HU HU2200459A patent/HUP2200459A2/hu unknown
- 2021-05-18 CA CA3178964A patent/CA3178964A1/en active Pending
- 2021-05-18 ES ES21726205T patent/ES2972189T3/es active Active
- 2021-05-18 LT LTEPPCT/IB2021/054261T patent/LT4153151T/lt unknown
- 2021-05-18 LU LU501245A patent/LU501245B1/fr active IP Right Grant
- 2021-05-18 US US17/925,515 patent/US20230190668A1/en active Pending
- 2021-05-18 DE DE112021002871.5T patent/DE112021002871T5/de active Pending
- 2021-05-18 PT PT217262054T patent/PT4153151T/pt unknown
- 2021-05-18 RS RS20240130A patent/RS65194B1/sr unknown
- 2021-05-18 MD MDE20230333T patent/MD4153151T2/ro unknown
- 2021-05-19 IE IE20210109A patent/IE20210109A1/en unknown
- 2021-05-19 TR TR2021/008324A patent/TR2021008324A2/tr unknown
- 2021-05-19 FR FR2105212A patent/FR3110397A1/fr active Pending
- 2021-05-20 BE BE20215409A patent/BE1028251B1/fr active IP Right Grant
- 2021-05-20 AR ARP210101380A patent/AR122136A1/es unknown
-
2022
- 2022-11-14 DK DKPA202201037A patent/DK202201037A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060078604A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
WO2006097149A1 (en) * | 2005-03-17 | 2006-09-21 | Pharmafilm S.R.L. | An aqueous polymeric system for pressure sensitive adhesive matrix preparation |
US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
WO2012089256A1 (en) * | 2010-12-29 | 2012-07-05 | Pharmafilm S.R.L. | Medicated patch for improved transdermal permeation of diclofenac diethylammonium |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101170705B1 (ko) | 아크릴 폴리머계 접착제 | |
JOP20190257A1 (ar) | مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats | |
ECSP23040022A (es) | Proceso para hacer un inhibidor de pd-1/pd-l1 y sales y formas cristalinas del mismo | |
AR116753A1 (es) | Proceso de preparación de un derivado de pirazolsulfonilamida | |
AR063259A1 (es) | Formas solidas de dosificacion farmaceuticas que comprenden compuestos microincluidos en polimeros ionicos insolubles en agua | |
BRPI0408690A (pt) | composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto | |
EP2981301A1 (de) | Medizinische auflage | |
NZ571818A (en) | External pharmaceutical composition comprising luliconazole and an alpha-hydroxycarboxylic acid such as lactic acid, glycolic acid or malic acid. | |
BR112018003823A2 (pt) | compostos auxiliares inibidores de metaloproteinase de matriz para dispositivos cirúrgicos | |
CO2019010078A2 (es) | Compuestos de pirimidinil-pyridiloxi-naftil y métodos para tratar enfermedades y trastornos relacionados con ire1 | |
BRPI0407375A (pt) | Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos | |
BRPI0512252A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto | |
KR20100044162A (ko) | 손상 회복 조성물 및 방법 | |
BRPI0408863A (pt) | composto, composição farmacêutica, método para tratar doenças, e, uso de um composto. | |
KR20140054248A (ko) | 함수 첩부제 | |
US8153742B2 (en) | Acrylic polymer-based adhesives | |
CO2022018636A2 (es) | Moduladores de il-17a | |
CO2022016899A2 (es) | Moduladores de il-17a | |
AT525409A3 (de) | Medizinisches Pflaster mit langsamer Freisetzung | |
BRPI0510451A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas de ppar(delta) e/ou de ppar(alfa) e sua utilização | |
BRPI0514412A (pt) | compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, sua utilização e método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas de ppar(gama) ppar(alfa) | |
WO2016097040A1 (de) | Mehrkomponentenklebstoff zur herstellung eines adhäsivhydrogels | |
BRPI0410266A (pt) | cristal, composto, processo para produzir um cristal, composição farmacêutica, inibidor de quinase, e, preventivo e/ou um remédio para doenças | |
RU2699661C1 (ru) | Способ лечения инфицированных ран у животных | |
CL2019002936A1 (es) | Uso de ácido 1-(aminometil) ciclohexanoacético para preparar un medicamento útil para el tratamiento y prevención de la enfermedad de alzheimer |